Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Greiner Bio-One Accelerates HPV Laboratory Diagnostics

Published: Monday, November 04, 2013
Last Updated: Monday, November 04, 2013
Bookmark and Share
At the international congress on HPV (human papilloma virus) and cervical cancer, Greiner Bio-One is presenting the latest clinical study on the PapilloCheck HPV test.

For what is now the seventh time, Greiner Bio-One GmbH will be presenting its products in the field of cervical cancer at the international EUROGIN congress. The new CheckExtractor is a leap in technology and a crucial step toward a fully automated HPV detection. The device replaces the manual process of extracting DNA from patient samples and preparing the PCR setup for subsequent analysis using PapilloCheck and PapilloCheck high-risk. This simplifies and cuts down on the work done by laboratory staff while simultaneously making it possible to process far more samples in consistently high quality. This is confirmed by Dr. Ron Opstelten, the new Director Sales & Marketing for the Diagnostics Business Unit at Greiner Bio-One GmbH: "The introduction of the CheckExtractor for automatic DNA purification marks the successful completion of the first phase of the work Greiner Bio-One is doing to fully automate the oCheck microarray applications". This was the company¹s response to customers¹ greatly increased analysis requirements in the field of human medicine laboratory diagnostics. "Together with the CheckProcessor now under development, this will mean that all the work needed to process samples can be completed as quickly as possible, based on the principle 'sample in - result out'," explains Opstelten.

Another key element of Greiner Bio-One¹s programme at Eurogin will be Dr.
Bart Hesselink¹s presentation on the recently concluded clinical study on PapilloCheck. His speech on 'Clinical validation of the PapilloCheck assay according to international guidelines for HPV test requirements for cervical screening' will examine the successful approval of the PapilloCheck HPV-DNA test by the Dutch Society for Pathology. The DNA test kit can analyse 18 high-risk types of HPV and 6 low-risk types in parallel, thus enabling early identification of a total of 24 carcinogenic virus types. With these innovative products for diagnostic medicine, Greiner Bio-One has made important progress toward enabling an early risk management for cervical cancer development, the second most common form of cancer in women.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!